Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03837600 · ClinicalTrials.gov registry record
Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung Cancer
A clinical trial, sponsored by bioAffinity Technologies.
- Completed
- Registry status
- 197
- Enrollment target
NCT03837600 is a clinical trial that has completed, run by bioAffinity Technologies. The registered enrollment target is 197 participants.
The verdict
NCT03837600 has completed, sponsored by bioAffinity Technologies.
- COMPLETED
- Registry status
- 197 participants
- Enrollment target
Study Summary
The primary objective of this study is optimization of the assay to discriminate between cancer cells and non-cancer cells in sputum samples by the performance of experiments that will determine methods to liquefy sputum, select proper fixatives and buffers, determine the efficacy of use of methyl-beta-cyclodextrin (MBCD) in sputum processing and determine the use of flow cytometry for high-throughput, and in the establishment of cell count and sputum cell populations in patient samples. The secondary objective of this study is comparison of the characteristics of sputum from three cohorts labeled with CyPath Lung to determine differential characteristics between samples taken from Participants who are not at high risk for lung cancer, Participants at high risk for lung cancer who are free of the disease and Participants with confirmed lung cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 197 participants |
| Start Date | 2016-09-22 |
| Est. Completion | 2018-08-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03837600
The ClinicalTrials.gov registry entry for NCT03837600 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 197 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is bioAffinity Technologies, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03837600 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03837600 about?
NCT03837600 is a clinical study titled "Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung Cancer". The primary objective of this study is optimization of the assay to discriminate between cancer cells and non-cancer cells in sputum samples by the performance of experiments that will determine methods to liquefy sputum, select proper fixatives and buffers, determine the efficacy of use of methyl-b...
What is the current status of trial NCT03837600?
This trial is currently completed. The enrollment target is 197 participants. The study started on 2016-09-22. Estimated completion is 2018-08-15.
Who is sponsoring clinical trial NCT03837600?
This trial is sponsored by bioAffinity Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.